Literature DB >> 11601894

Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain.

C Danve1, G Decaussin, P Busson, T Ooka.   

Abstract

The Epstein-Barr virus (EBV) is associated with two major human epithelial malignancies, where it is likely to play a role in the malignant phenotype: undifferentiated nasopharyngeal carcinoma (100% of cases) and gastric carcinomas (about 10% of cases). We and others have obtained growth transformation of monkey kidney primary epithelial cells by transfection of viral DNA, especially with the BARF1 gene of EBV (Wei et al., 1997). We now report that the same type of primary epithelial cells can be growth-transformed using EBV particles derived from a nasopharyngeal carcinoma tumor line. Not only can these EBV-infected cells grow over 100 passages, escaping senescence, in contrast to their noninfected counterparts, but they can also survive and proliferate at very low cell density. Several subclones were characterized in terms of viral gene expression. All these clones gave a similar pattern, with detection of EBNA1 and BARF1 proteins but absence of LMP1. CD21, which is the main EBV receptor on B lymphocytes, was not expressed on parental monkey kidney epithelial cells nor on EBV-infected cell clones. This model of epithelial cell transformation will be useful for a better investigation of EBV functions critical for oncogenesis of epithelial cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601894     DOI: 10.1006/viro.2001.1072

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells.

Authors:  Richeng Jiang; Giulia Cabras; Wang Sheng; Yixin Zeng; Tadamasa Ooka
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

2.  BARF1 gene silencing triggers caspase-dependent mitochondrial apoptosis in Epstein-Barr virus-positive malignant cells.

Authors:  Taznim Begam Mohd Mohidin; Ching Ching Ng
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

3.  Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1.

Authors:  Ann Hye-Ryong Shim; Rhoda Ahn Chang; Xiaoyan Chen; Richard Longnecker; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.

Authors:  Mee Soo Chang; Dong Ha Kim; Jin Kyung Roh; Jaap M Middeldorp; Yang Soo Kim; Sunghan Kim; Seungbong Han; Chul Woo Kim; Byung Lan Lee; Woo Ho Kim; Jun Hee Woo
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 5.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

6.  Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR.

Authors:  R Serene Perkins; Katherine Sahm; Cindy Marando; Diana Dickson-Witmer; Gregory R Pahnke; Mark Mitchell; Nicholas J Petrelli; Irving M Berkowitz; Patricia Soteropoulos; Virginie M Aris; Stephen P Dunn; Leslie J Krueger
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

7.  Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells.

Authors:  Sylvie Fiorini; Tadamasa Ooka
Journal:  Virol J       Date:  2008-06-04       Impact factor: 4.099

Review 8.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

Review 9.  Oncogenes and RNA splicing of human tumor viruses.

Authors:  Masahiko Ajiro; Zhi-Ming Zheng
Journal:  Emerg Microbes Infect       Date:  2014-09-03       Impact factor: 7.163

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.